Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 27, 2022

Investigating the Role of Somatic Sequencing Platforms for Phaeochromocytoma and Paraganglioma

Clinical endocrinology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical endocrinology
Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort
Clin. Endocrinol. (Oxf) 2021 Dec 06;[EPub Ahead of Print], B Winzeler, N Tufton, E S Lim, BG Challis, SM Park, L Izatt, PV Carroll, A Velusamy, T Hulse, BC Whitelaw, E Martin, F Rodger, M Maranian, GR Clark, S A Akker, ER Maher, RT Casey

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading